ArticleNature communications2022

Targeting TCTP sensitizes tumor to T cell-mediated therapy by reversing immune-refractory phenotypes.

Hyo-Jung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.